glp-1 agonists oral Comparing Ozempic, Wegovy and Other Drugs GLP-1 medicines started with injectable
Description
Mazidi M, Rezaie P, Gao HK, Kengne AP
has received study medication from Bausch Health
doi: 10.1038/d41586-018-05719-4 37 SerOPovovJMekIPekLJanoutV
Clinical research on the FDA-approved branded versions of these active ingredients includes the STEP-1 trial, which demonstrated mean weight reduction of approximately 14.9% with semaglutide over 68 weeks, and the SURMOUNT-1 trial, which showed tirzepatide achieving 1622.5% weight reduction over 72 weeks
R., & Su, S
95%CI 0.58 0.95
